Remifentanil Hydrochloride Injection
Mylan Institutional, a Viatris Company · Available
Open FDA's page for this record- Update type
- Reverified
- Initial posting date
- 06/28/2022
- Package NDC
- 72078-036-05
- Generic name
- Remifentanil Hydrochloride Injection
- Contact info
- 800-796-9526
- Availability
- Available
- Update date
- 09/17/2026
- Dosage form
- Injection
- Presentation
- Ultiva, Injection, 5 mg (NDC 72078-036-05)
- Company name
- Mylan Institutional, a Viatris Company
- Status
- Current
- Therapeutic category
- Analgesia/Addiction
- Harmonized identifiers (openFDA)
- Application number
- NDA020630
- Brand name
- ULTIVA
- Generic name
- REMIFENTANIL HYDROCHLORIDE
- Manufacturer name
- Mylan Institutional LLC
- Product NDC
- 72078-036, 72078-034, 72078-035
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- INTRAVENOUS
- Substance name
- REMIFENTANIL HYDROCHLORIDE
- RxCUI
- 1729578, 1729581, 1729584, 1729586, 1729710, 1729712
- SPL ID
- f41b6542-9305-43e7-bbbc-52c7ee2cb0dc
- SPL set ID
- 8b4c8696-e23e-4c51-a4d2-babab5bd945a
- Package NDC
- 72078-034-00, 72078-034-01, 72078-035-00, 72078-035-02, 72078-036-00, 72078-036-05
- UNII
- 5V444H5WIC